These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 35976535)

  • 1. Chemogenetic and Optogenetic Manipulations of Microglia in Chronic Pain.
    Parusel S; Yi MH; Hunt CL; Wu LJ
    Neurosci Bull; 2023 Mar; 39(3):368-378. PubMed ID: 35976535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic activation of spinal microglia triggers chronic pain in mice.
    Yi MH; Liu YU; Umpierre AD; Chen T; Ying Y; Zheng J; Dheer A; Bosco DB; Dong H; Wu LJ
    PLoS Biol; 2021 Mar; 19(3):e3001154. PubMed ID: 33739978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemogenetic modulation of astrocytes and microglia: State-of-the-art and implications in neuroscience.
    Bossuyt J; Van Den Herrewegen Y; Nestor L; Buckinx A; De Bundel D; Smolders I
    Glia; 2023 Sep; 71(9):2071-2095. PubMed ID: 37222453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice.
    Yi MH; Liu YU; Liu K; Chen T; Bosco DB; Zheng J; Xie M; Zhou L; Qu W; Wu LJ
    Brain Behav Immun; 2021 Feb; 92():78-89. PubMed ID: 33221486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning neural circuits and behaviors by microglia in the adult brain.
    Zhao S; Umpierre AD; Wu LJ
    Trends Neurosci; 2024 Mar; 47(3):181-194. PubMed ID: 38245380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic and chemogenetic modulation of astroglial secretory phenotype.
    Salmina AB; Gorina YV; Erofeev AI; Balaban PM; Bezprozvanny IB; Vlasova OL
    Rev Neurosci; 2021 Jul; 32(5):459-479. PubMed ID: 33550788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-innervating TRPV1+ Neurons Drive Chronic Visceral Pain via Microglial P2Y12 Receptor.
    Defaye M; Abdullah NS; Iftinca M; Hassan A; Agosti F; Zhang Z; Cumenal M; Zamponi GW; Altier C
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):977-999. PubMed ID: 34954381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates.
    Galvan A; Caiola MJ; Albaugh DL
    J Neural Transm (Vienna); 2018 Mar; 125(3):547-563. PubMed ID: 28238201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studying brain-regulation of immunity with optogenetics and chemogenetics; A new experimental platform.
    Ben-Shaanan T; Schiller M; Rolls A
    Brain Behav Immun; 2017 Oct; 65():1-8. PubMed ID: 27890661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Optogenetic and Chemogenetic Control of Neurons.
    Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
    Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limitations of investigating appetite through circuit manipulations: are we biting off more than we can chew?
    Wang J; Beecher K; Chehrehasa F; Moody H
    Rev Neurosci; 2023 Apr; 34(3):295-311. PubMed ID: 36054842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optogenetic and chemogenetic therapies for epilepsy.
    Walker MC; Kullmann DM
    Neuropharmacology; 2020 May; 168():107751. PubMed ID: 31494141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DREADDed microglia in pain: Implications for spinal inflammatory signaling in male rats.
    Grace PM; Wang X; Strand KA; Baratta MV; Zhang Y; Galer EL; Yin H; Maier SF; Watkins LR
    Exp Neurol; 2018 Jun; 304():125-131. PubMed ID: 29530713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optogenetics and Chemogenetics.
    Vlasov K; Van Dort CJ; Solt K
    Methods Enzymol; 2018; 603():181-196. PubMed ID: 29673525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of DREADDs to Deconstruct Behavior.
    Whissell PD; Tohyama S; Martin LJ
    Front Genet; 2016; 7():70. PubMed ID: 27242888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing Neurons: Tools, Applications, and Experimental Constraints.
    Wiegert JS; Mahn M; Prigge M; Printz Y; Yizhar O
    Neuron; 2017 Aug; 95(3):504-529. PubMed ID: 28772120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling.
    Liu YU; Ying Y; Li Y; Eyo UB; Chen T; Zheng J; Umpierre AD; Zhu J; Bosco DB; Dong H; Wu LJ
    Nat Neurosci; 2019 Nov; 22(11):1771-1781. PubMed ID: 31636449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Chemogenetics and Optogenetics to Dissect Brain-Immune Interactions.
    Korin B; Rolls A
    Methods Mol Biol; 2018; 1781():195-208. PubMed ID: 29705849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational PET applications for brain circuit mapping with transgenic neuromodulation tools.
    Boehm MA; Bonaventura J; Gomez JL; Solís O; Stein EA; Bradberry CW; Michaelides M
    Pharmacol Biochem Behav; 2021 May; 204():173147. PubMed ID: 33549570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats.
    Campbell EJ; Marchant NJ
    Br J Pharmacol; 2018 Apr; 175(7):994-1003. PubMed ID: 29338070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.